Skip to main content


Full Schedule

Full Schedule

  • Thursday, October 7, 2021
  • 10:00 AM – 11:05 AM EDT
    Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 Pandemic
  • 10:00 AM – 8:15 PM EDT
    Industry Encore Posters
  • 11:15 AM – 12:00 PM EDT
    Clinically Relevant Drug Interactions in the Cancer Setting
  • 12:15 PM – 1:00 PM EDT
    Considerations for the Treatment of Patients With Lung Cancer: Resectable NSCLC and Unresectable Stage III NSCLC - AstraZeneca
  • 1:00 PM – 1:45 PM EDT
    Moderated Clinical Posters
  • 1:45 PM – 2:15 PM EDT
    Micro-Community Meet Up
  • 2:15 PM – 3:00 PM EDT
    Immunotherapies for the Treatment of Triple-Negative Breast Cancer
  • 3:15 PM – 4:00 PM EDT
    Managing Immune-related Adverse Events with Checkpoint Inhibitors - GSK
  • 4:15 PM – 4:45 PM EDT
    Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
  • 5:15 PM – 6:00 PM EDT
    Product Theater
  • 6:15 PM – 7:15 PM EDT
    Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 Pandemic
  • 7:30 PM – 8:15 PM EDT
    Clinically Relevant Drug Interactions in the Cancer Setting